Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q4 2025 Earnings Call Transcript February 26, 2026
Kymera Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.03128 EPS, expectations were $-0.77.
Operator: Good day, everyone. My name is Kahai Illani, and I will be your conference operator today. At this time, I would like to welcome you to the Kymera Therapeutics Fourth Quarter 2025 Results Call. [Operator Instructions] At this time, I would like to turn the call over to Justine...
